Content about Bayer

May 3, 2013

Bayer Healthcare on Friday partnered with Sheryl Crow in support of Feeding America for that group's "Nutrition Mission."

MORRISTOWN, N.J. — Bayer Healthcare on Friday partnered with Sheryl Crow in support of Feeding America for that group's "Nutrition Mission."

Through July 28, for every bottle of One-A-Day Women's purchased, Bayer will donate two meals, up to 2 million (valued at $500,000), to Feeding America. 

May 2, 2013

Bayer HealthCare has introduced a product for controlling fleas and ticks in dogs and cats that lasts eight months, the company's animal health division said Thursday.

SHAWNEE, Kan. — Bayer HealthCare has introduced a product for controlling fleas and ticks in dogs and cats that lasts eight months, the company's animal health division said Thursday.

Seresto is a collar that is designed to provide protection from parasites similar to that provided by monthly topical medications. The collar's active ingredients are flumethrin and imidacloprid, and the company said it kills fleas within 24 hours and ticks within 48 hours after application.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

LEVERKUSEN, Germany — Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

Bayer said its $31-per-share purchase of the Mountain View, Calif.-based company would allow it to expand its selection of contraception products. Conceptus makes Essure, a non-surgical permanent birth-control method, and Bayer said it would allow the company to offer a complete range of short-term, long-term and permanent contraceptive methods for women.

April 18, 2013

A federal court ruling has allowed Actavis to relaunch a generic contraceptive drug, the company said.

PARSIPPANY, N.J. — A federal court ruling has allowed Actavis to relaunch a generic contraceptive drug, the company said.

April 4, 2013

The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.

The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.

March 12, 2013

The former president of Bayer HealthCare's Worldwide Consumer Care Division has won a lifetime-achievement award from a trade group focused on the OTC industry.

WASHINGTON — The former president of Bayer HealthCare's Worldwide Consumer Care Division has won a lifetime-achievement award from a trade group focused on the OTC industry.

The Consumer Healthcare Products Association announced that it gave its Ivan D. Combe Lifetime Achievement Award to Gary Balkema at its annual executive conference in Naples, Fla.

March 8, 2013

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls.

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls. Within internal analgesic tablets, sales of store brand equivalents were up 15% off of a 2011 base of around $1.2 billion. The branded competition also were benefactors — both Pfizer's Advil and Bayer's Aleve generated more than $50 million in incremental sales on top of 2011 sales.

February 25, 2013

The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

The FDA announced the approval of Stivarga (regorafenib) for gastrointestinal stromal tumors that could not be removed through surgery or had spread to other parts of the body and were no longer responding to treatment with Novartis' Gleevec (imatinib) or Pfizer's Sutent (sunitinib).

January 28, 2013

The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.

The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.

Click here for the complete guide.

January 15, 2013

Bayer HealthCare’s Animal Health Division recently introduced Resultix, a spray-on formula that kills attached or crawling ticks.

SHAWNEE MISSION, Kan. — Bayer HealthCare’s Animal Health Division recently introduced Resultix, a spray-on formula that kills attached or crawling ticks. Ticks can infest pets in very large numbers. Resultix is an easy-to-use spray formula that works by dissolving the outer wax layer that covers a tick’s hard shell, killing the parasite within three hours.

Resultix can safely be used as often as needed on crawling or attached ticks. The product is available in an easy-to-transport 20-mL bottle.

 

January 15, 2013

CVS/pharmacy has decided to stock Tylenol pain reliever in only half of its stores, according to a Reuters report published Monday.

NEW YORK — CVS/pharmacy has decided to stock Tylenol pain reliever in only half of its stores, according to a Reuters report published Monday. 

According to the report, CVS will stock Tylenol in each market, but not in each store as CVS seeks to plug any out-of-stock holes left behind by the initial recall of Tylenol three years ago and the brand's slow trek back to shelf. 

January 15, 2013

Interest in vitamins, minerals and supplements as a viable consumer product with strong profit-bearing potential has got to be at an all-time high right now, judging from the number of merger and acquisition deals scrolling across the latest finance news feeds.

Interest in vitamins, minerals and supplements as a viable consumer product with strong profit-bearing potential has got to be at an all-time high right now, judging from the number of merger and acquisition deals scrolling across the latest finance news feeds.

January 10, 2013

The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.

WAYNE, N.J. — The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.

Bayer announced the approval of Skyla (levonorgestrel-releasing uterine system), which can prevent pregnancy for up to three years. The IUD contains 13.5 mg of levonorgestrel.

Nearly 50% of pregnancies in the United States are unintended, according to the National Center for Health Statistics.

November 30, 2012

Bayer HealthCare's animal-health division has introduced a new spray for killing ticks in cats and dogs, the company said.

SHAWNEE, Kan. — Bayer HealthCare's animal-health division has introduced a new spray for killing ticks in cats and dogs, the company said.

The company debuted Resultix at the opening of BarkWorld Expo, a pet social media conference in Atlanta that took place on Oct. 26.

The spray is designed to dissolve the outer wax layer that covers the tick's cuticle, its hard shell, resulting in the parasite's uncontrollable water loss and death within three hours.

November 28, 2012

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

Click here for the complete guide.

November 26, 2012

Reckitt Benckiser successfully wrapped up its pursuit of Schiff Nutrition on Friday with the signing of a definitive merger agreement in a deal valued at $1.4 billion. Bayer officially relinquished its proposed acquisition on the same day.

SLOUGH, England — Reckitt Benckiser successfully wrapped up its pursuit of Schiff Nutrition on Friday with the signing of a definitive merger agreement in a deal valued at $1.4 billion. Bayer officially relinquished its proposed acquisition on the same day. 

November 20, 2012

Bayer will not be raising its offer for Schiff Nutrition to match or exceed last week's bid from Reckitt Benckiser, Reuters reported Tuesday morning.

NEW YORK — Bayer will not be raising its offer for Schiff Nutrition to match or exceed last week's bid from Reckitt Benckiser, Reuters reported Tuesday morning. 

Bayer's bid is still active, however, and is in discussions with Schiff to acquire the company for its original evaluation of $1.2 billion. Reckitt Benckiser bid $1.4 billion. 

To read the Reuters report, click here

November 16, 2012

The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.

SLOUGH, England — The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.

November 16, 2012

Reckitt Benckiser on Friday made an offer to acquire all of the outstanding shares of VMS maker Schiff Nutrition for $42 per share in cash, or approximately $1.4 billion — a premium of 23.5% more than the $34 per share offer Bayer HealthCare announced Oct. 30.

NEW YORK — Reckitt Benckiser on Friday made an offer to acquire all of the outstanding shares of VMS maker Schiff Nutrition for $42 per share in cash, or approximately $1.4 billion — a premium of 23.5% more than the $34 per share offer Bayer HealthCare announced Oct. 30. 

November 14, 2012

Bayer Healthcare on Wednesday announced that they have teamed up with Vitamin Angels to launch 10 Million Stronger, a charitable initiative aimed at delivering vitamin A to 10 million children worldwide who are suffering from vitamin A deficiency.

MORRISTOWN, N.J. — Bayer Healthcare on Wednesday announced that they have teamed up with Vitamin Angels to launch 10 Million Stronger, a charitable initiative aimed at delivering vitamin A to 10 million children worldwide who are suffering from vitamin A deficiency.

November 2, 2012

Bayer on Friday announced that it is providing monetary support for disaster relief efforts through donations totaling $150,000 from the Bayer USA Foundation.

PITTSBURGH — Bayer on Friday announced that it is providing monetary support for disaster relief efforts through donations totaling $150,000 from the Bayer USA Foundation. 

The American Red Cross and Save the Children will each receive $75,000. 

“When millions of people are affected by devastation in the form of natural disasters, it is important to be able to provide assistance to families and communities in a time of great need,” stated Tracy Spagnol, chairperson of the Bayer USA Foundation.

October 31, 2012

Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne.

MORRISTOWN, N.J. — Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne. These four products accounted for 70% of all Schiff sales, noted Marijn Dekkers, Bayer CEO, during an analyst call Wednesday morning. "This acquisition will strengthen Bayer's leading OTC business and complement our existing nutritionals business with well-established strong brands," he said. 

October 4, 2012

The September/October 2012 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums, Di-Gel, Zantac, Pepcid AC, Prilosec OTC, Prevacid 24HR, Dulcolax, Senokot and Pepto-Bismol.

The September/October 2012 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums, Di-Gel, Zantac, Pepcid AC, Prilosec OTC, Prevacid 24HR, Dulcolax, Senokot and Pepto-Bismol.

Click here for the complete guide.

September 28, 2012

Bayer HealthCare has signed a deal with a pet expert in a campaign focused on cat health, the company said Friday.

NEW YORK — Bayer HealthCare has signed a deal with a pet expert in a campaign focused on cat health, the company said Friday.

Bayer's animal health division announced that it had hired Wendy Diamond and her Russian blue cat, Pasha, to dispel popular myths about cats and promote its flea treatment, Advantage II. Diamond has appeared on television shows such as "Good Morning America" and "The Today Show" as well as in other media outlets.

September 27, 2012

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.

Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.